| 95.4 -1.46 (-1.51%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 134.35 | 1-year : | 155.39 |
| Resists | First : | 115.03 | Second : | 133.03 |
| Pivot price | 93.83  |
|||
| Supports | First : | 85.9 | Second : | 71.46 |
| MAs | MA(5) : | 92.86  |
MA(20) : | 96.16 |
| MA(100) : | 76.61 |
MA(250) : | 42.83 |
|
| MACD | MACD : | -3.7 |
Signal : | -3.8 |
| %K %D | K(14,3) : | 36.8 |
D(3) : | 27.6 |
| RSI | RSI(14): 47.4 |
|||
| 52-week | High : | 133.03 | Low : | 7.48 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AGL ] has closed below upper band by 42.7%. Bollinger Bands are 34.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 99.74 - 100.41 | 100.41 - 100.96 |
| Low: | 93.61 - 94.24 | 94.24 - 94.77 |
| Close: | 94.47 - 95.5 | 95.5 - 96.36 |
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
Tue, 18 Aug 2026
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Mon, 17 Aug 2026
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sat, 15 Aug 2026
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Fri, 14 Aug 2026
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Fri, 14 Aug 2026
Agilon Health (NYSE:AGL) Trading 8.5% Higher - Here's What Happened - MarketBeat
Fri, 14 Aug 2026
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 17 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 3.1 (%) |
| Held by Institutions | 94.2 (%) |
| Shares Short | 859 (K) |
| Shares Short P.Month | 647 (K) |
| EPS | -15.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.56 |
| Profit Margin | -4 % |
| Operating Margin | 1.2 % |
| Return on Assets (ttm) | -9.7 % |
| Return on Equity (ttm) | -79 % |
| Qtrly Rev. Growth | 7.1 % |
| Gross Profit (p.s.) | 0.82 |
| Sales Per Share | 352.59 |
| EBITDA (p.s.) | -14.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -72 (M) |
| Levered Free Cash Flow | -146 (M) |
| PE Ratio | -6.27 |
| PEG Ratio | 0 |
| Price to Book value | 7.03 |
| Price to Sales | 0.27 |
| Price to Cash Flow | -22.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|